Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine, Modified Live Virus
171 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
171
Total Reports
9
Deaths Reported
530.0%
Death Rate
Active Ingredients
Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine, Modified Live Virus
Administration Routes
SubcutaneousParenteralUnknownSubconjunctivalOther
Species Affected
Dog 171
Most Affected Breeds
Retriever - Labrador 15
Chihuahua 13
Shepherd Dog - Australian 10
Maltese 8
Retriever - Golden 8
Shih Tzu 7
Bulldog - French 7
Terrier - Boston 6
Terrier - Yorkshire 5
Pug 5
Most Reported Reactions
Vomiting 54
Diarrhoea 21
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 21
Lethargy (see also Central nervous system depression in 'Neurological') 18
Other abnormal test result NOS 17
Facial swelling (see also 'Skin') 13
Anaphylaxis 9
Fever 8
Lethargy (see also Central nervous system depression in Neurological) 8
Not eating 7
Facial swelling (see also Skin) 7
Emesis (multiple) 6
Outcome Breakdown
Recovered/Normal
68 (39.8%)
Outcome Unknown
66 (38.6%)
Ongoing
28 (16.4%)
Died
5 (2.9%)
Euthanized
4 (2.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.